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ABSTRACT
Objectives: Female condoms are the only female-
initiated HIV and pregnancy prevention technology
currently available. We examined female condom
counselling and provision among providers in South
Africa and Zimbabwe, high HIV-prevalence countries.
Design: A cross-sectional study using a nationally
representative survey.
Setting: All facilities that provide family planning
or HIV/sexually transmitted infection (STI) services.
Participants: National probability sample of 1444
nurses and physicians who provide family planning
or HIV/STI services.
Primary and secondary outcome measures:
Female condom practices with different female
patients, including adolescents, married women,
women using hormonal contraception and by HIV
status. Using multivariable logistic analysis, we
measured variations in condom counselling by
provider characteristics.
Results: Most providers reported offering female
condoms (88%; 1239/1415), but perceived a need for
novel female barrier methods for HIV/STI prevention
(85%; 1191/1396). By patient type, providers reported
less frequent female condom counselling of
adolescents (55%; 775/1411), women using hormonal
contraception (65%; 909/1409) and married women
(66%; 931/1416), compared to unmarried (74%;
1043/1414) or HIV-positive women (82%; 1161/1415).
Multivariable results showed providers in South Africa
were less likely to counsel women on female condoms
than in Zimbabwe (OR=0.48, 95% CI 0.35 to 0.68,
p≤0.001). However, South African providers were
more likely to counsel women on male condoms
(OR=2.39, 95% CI 1.57 to 3.65, p≤0.001). Nurses
counselled patients on female condoms more
frequently than physicians (OR=5.41, 95% CI 3.26 to
8.98, p≤0.001). HIV training, family planning training,
location (urban vs rural) and facility type (hospital vs
clinic) were not associated with greater condom
counselling.
Conclusions: Female condoms were integrated into
provider counselling and care, although providers
reported a need for new female-initiated multipurpose
prevention technologies, suggesting female condoms
do not meet all patient/provider needs or are not
adequately well known or accessible. Providers should
be included in HIV training efforts to raise awareness
of new and existing products, and encouraged to
educate all women.
ARTICLE SUMMARY
Article focus
▪ A cross-sectional study examining current female
condom (FC) counselling and provision practices
among a nationally representative sample of health-
care providers in South Africa and Zimbabwe.
▪ Assessment of whether providers view FCs as
more appropriate for certain types of patients,
and how their FC practices varied compared with
those for male condoms.
Key messages
▪ Most providers reported offering FCs (more so in
Zimbabwe than in South Africa) but perceived a
need for novel female barrier methods for HIV/
sexually transmitted infection prevention, suggest-
ing FCs do not meet all patient/provider needs or
are not adequately well known or accessible.
▪ Providers reported less-frequent FC counselling
of adolescents, women using hormonal contra-
ception and married women, compared with
unmarried or HIV-positive women, suggesting
the need for training, emphasising the import-
ance of FC counselling with all women.
▪ Providers should be included in HIV training
efforts to raise awareness of new and existing
products.
Strengths and limitations of this study
▪ This is the first nationally representative survey
in South Africa or Zimbabwe examining FC coun-
selling and provision and we obtained high
response rates; thus, we are able to generalise to
the entire provider populations of these two high
HIV prevalence countries.
▪ Potential social desirability bias may have influ-
enced responses towards more comprehensive
levels of prevention counselling.
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INTRODUCTION
There is growing recognition that no single intervention
will be sufficient to halt the HIVepidemic and that combin-
ation prevention strategies tailored to the needs of specific
populations have the most potential for decreasing HIV
infection rates.1 The female condom (FC) is the only avail-
able alternative to the male condom that provides protec-
tion from both HIV/sexually transmitted infection (STI)
infection and pregnancy, and it is a method that women
can initiate. A review of research on the FC concluded that
increased access to the method leads to an increase in pro-
tected sex in a population, and decreased STI incidence.2
There have been promising results from recent clinical
trials testing the effectiveness of novel woman-initiated
methods of HIV prevention, including microbicides3 and
pre-exposure prophylaxis, which were recently endorsed by
the Centers for Disease Control and Prevention (CDC) in
the USA for use by heterosexual women at very high risk
for HIV infection (eg, women with HIV-positive sex part-
ners).4 However, conclusive proof of effectiveness and regis-
tration of a new woman-initiated HIV-prevention product
recommended for widespread use is unlikely for a number
of years, and the FC will remain an important option for
women who desire pregnancy prevention and STI protec-
tion from a single product.
In sub-Saharan Africa, women are at increased risk of
HIV/AIDS and heterosexual sex is the predominant mode
of transmission.5 HIV prevalence among women was esti-
mated at 33% in the peak ages (25–29 years) in South
Africa in 2008 and 29% in Zimbabwe (30–39 years) in
2010–2011.6 7 Among young people aged 15–24, HIV preva-
lence was 8.6% in South Africa in 2008 and 5.5% in
Zimbabwe in 2010–2011.6 7 Additionally, 24% of married
women and 9% of never-married women in sub-Saharan
Africa have an unmet need for contraception—rates higher
than elsewhere in the developing world.8 In South Africa
and Zimbabwe, reported use of the FC is less than 1% com-
pared with 4–6% use of male condoms among married
women in peak ages of HIV prevalence (25–29 years in
South Africa and 30–39 years in Zimbabwe).7 9
Since the US Food and Drug Administration (USFDA)
approved the first available product—the FC1—in 1993,
there has been a lack of commitment and resources to
expand access to the FC among the international policy
community.10 In 2009, the USFDA approved a second-
generation FC called FC2 made of synthetic latex rather
than polyurethane. The FC2 is less expensive and makes
less noise when used;10 other new FC technologies are
in development and could reduce costs further. In add-
ition, the 2010 and 2011 US President’s Emergency Plan
for AIDS Relief (PEPFAR) Fiscal Year Country Operational
Plan Guidance specifically mentioned the importance of
FCs in country programme plans and the Caucus on
New and Underused Reproductive Health Technologies
recently named the FC as one of several ‘underused’
reproductive health technologies.11 12 These new pro-
ducts and policy developments are positive signs of
increased support for the FC.
Healthcare provider participation, however, is essential
to the success of FC programmes. Even if countries
procure significant supplies, women and men may have
limited knowledge and access if providers do not discuss
and provide FCs. Unlike the male condom, the FC is
typically obtained through provider contact (not dispen-
sers) in the public sector with no cost to the user,
although in some settings there is also a strong presence
of social marketing campaigns. Training and accurate
information from providers could increase acceptability
and sustained use of the FC.10
Few studies have examined counselling and provision
practices for FCs in sub-Saharan Africa. Three early case
studies exploring family planning providers’ attitudes
about the FC in South Africa and Nigeria (where the FC
was not yet introduced in the public sector), and the USA
found that US providers lacked knowledge on the FC
despite product availability and saw the method as appro-
priate only for certain women, such as sex workers or
HIV-positive women.13 In the USA and South Africa, provi-
ders reported negative attitudes about the aesthetics and
use of the FC, although providers in South Africa were
more enthusiastic after receiving training. In a study of vol-
untary counselling and testing counsellors in Kenya, many
counsellors recognised the need for a female-initiated pre-
vention method but felt uncomfortable with FCs or
expressed concern about counselling when FCs were not
widely available.14 In another small qualitative study of pro-
vider FC opinions in Kenya, several healthcare providers
reported support for FCs owing to the belief that FCs give
women ‘choice’ and ‘control.’15 These studies, albeit small
and non-generalisable, suggest a need for further invest-
ment in supporting providers to counsel and offer women
the FC.
In this nationally representative study of physicians
and nurses, we examined FC counselling and provision
practices in South Africa and Zimbabwe. The two coun-
tries have different histories of FC introduction that
could impact provision at the health service level.
Zimbabwe was one of the first countries to introduce
FCs in 1997 through the public sector and innovative
social marketing campaigns. Scale-up of male condoms
and FCs in recent years has been based on a national
comprehensive behaviour change strategy to reduce
sexual transmission of HIV, and FCs are now offered in
all public sector facilities.16 17 FC distribution in the
public sector in Zimbabwe increased from about 400 000
in 2005 to more than 2 000 000 in 2008 and social mar-
keting sales have risen from about 900 000 in 2005 to
more than 3 000 000 in 2008.16 South Africa introduced
the FC shortly after Zimbabwe in 1998 primarily through
public sector family planning clinics and community-
based programmes.18 FC distribution in South Africa is
among the highest in the world (4.3 million FCs distrib-
uted in public sector in 2008);19 however, FCs are not
yet available in all public sector facilities in South Africa
and proportional to population size (the population of
South Africa is approximately four times that of
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Zimbabwe), Zimbabwe has higher distribution rates.
Given these distribution efforts to increase stocking and
availability in both countries, we still lack national esti-
mates of how many providers are able to offer FCs to
patients.
We investigated counselling and provision practices
among a nationally representative sample of providers to
gauge the prevention services offered to a range of
patients in varied clinical settings. We assessed whether
providers view FCs as more appropriate for certain types
of patients, and how their FC counselling practices
varied compared to those for male condoms. The results
have the potential to inform efforts to prepare providers
to expand access to this female-initiated prevention
method for their patients.
METHODS
This study is part of a mixed-methods research project
in Southern Africa investigating providers’ pregnancy
and STI/HIV prevention practices. We completed
national probability surveys of physicians and nurses in
South Africa and Zimbabwe in 2009. Participants
answered a series of questions on female and male
condoms counselling and provision practices, as well as
demographic and professional practice characteristics
and patient population. The surveys were preceded by
60 in-depth interviews of providers serving female
patients at risk of HIV, which revealed their views of FC
use within their patient populations.
We used a multistage, facility-based approach to gener-
ate a national probability survey sample of providers. We
randomly selected districts (with probability propor-
tional to size, based on estimated numbers of physicians
and nurses), then facilities that provided family planning
or HIV/STI services within those districts (stratified by
type—hospital or clinic—and probability proportional to
size), and recruited all providers from those facilities
who provided family planning or HIV/STI services. The
sample consists of public facilities in South Africa and
Zimbabwe. Some non-governmental organisations are
included in Zimbabwe as they deliver primary care, and
specifically family planning, to low-income populations.
The final sample included 1019 providers representing
116 facilities (or 89% of the total 130 selected facilities)
from South Africa and 953 providers representing 130
facilities from Zimbabwe (94% of the total 138 facilities
selected). The methodology has been described in
detail elsewhere.20
Data were collected via self-administered questionnaires
distributed in-person in Zimbabwe and telephone-
administered questionnaires in South Africa (costs of
in-person visits were prohibitive owing to the large country
size). Approvals were granted as required in each country,
at the national, provincial, district and facility levels. In
South Africa, provincial approval was granted, as well as
district-level approval where required by the facility. In
Zimbabwe, approval was granted at the national level, and
either the provincial or district level, as needed. The
study was approved by the University of KwaZulu-Natal
Biomedical Research Ethics Administration, the Medical
Research Council of Zimbabwe, the Western Institutional
Review Board and the University of California,
San Francisco Committee on Human Research.
Providers were asked whether they currently provide the
FC and the male condom, and whether they would like to
receive more training (yes/no). Providers were also asked
about the frequency of female (and male) condom coun-
selling, on a four-point Likert scale (never, sometimes,
usually or always), with the following types of female
patients: women in general, female teenagers, HIV-positive
women, married women, unmarried women and women
using hormonal contraception. They were asked whether
they believe FCs are appropriate contraceptives for women
at risk of HIV infection (yes/no) and HIV-positive women
(yes/no), whether they routinely talk to female patients
about pregnancy and HIV/STI prevention during the
same visit (yes/no), and how much of a need there is for
more female barrier methods for HIV/STI prevention (on
a scale of 1–10).
We assessed clinician practices by country for different
types of female patients in these high HIV prevalence set-
tings, using χ2-statistics for categorical variables and t tests
for continuous variables. We analysed condom counselling
practices with multivariable logistic regression to assess FC
counselling by provider and practice-related characteris-
tics. We also analysed male condom counselling practices
for comparison using the same set of predictors. The two
outcome variables were routine (usually/always) counsel-
ling on FCs and routine counselling on male condoms.
We adjusted analyses for the facility-based sampling
scheme to account for clustering at the facility level. We
used Stata V.11.0 (College Station, Texas, USA) for ana-
lyses. Significance was defined as p<0.05. We conducted
thematic analysis of qualitative data to investigate open-
ended provider responses about their counselling and pro-
vision practices.
RESULTS
A total of 614 providers from South Africa and 830 pro-
viders from Zimbabwe completed the survey (N=1444)
with an overall response rate of 73.2%. In South Africa,
the response rate did not differ between hospitals (61%)
and clinics (60%), though nurses were more likely to
respond than physicians (66% vs 39%). In Zimbabwe,
providers in hospitals were more likely to respond than
in clinics (92% vs 81%), and physicians were more likely
to respond than nurses (100% vs 87%). The most
common reason for not responding was busy clinic load
or that the staff were not at the clinic. The majority sur-
veyed in both countries were nurses (91%; table 1).17
Ninety-six per cent of the nurses were female, and
overall 86% of participants were female. Most reported
prior training in HIV prevention (80%) and family plan-
ning (63%). Participants were split between hospital
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(55%) and clinic (45%) settings, and urban (48%) and
rural (52%) areas. Virtually all providers served adult
women of reproductive age (99.7%), female teens
(98%) and the majority also saw male patients (86%).
The majority (70%) reported that most or all of their
patients are at risk for HIV.
Almost all (99%) providers reported currently offering
male condoms to patients (table 2). A large majority in
both countries (88%) reported offering FCs, with a lower
proportion in South Africa (80%) than Zimbabwe (94%;
p≤0.001). While most physicians offer FCs (72%), a signifi-
cantly higher proportion of nurses do (89%; p≤0.001).
Availability is an important factor in being able to offer a
method, and 27% of providers reported they would offer
FCs if more easily available. Among the small proportion
currently not offering FCs (13% n=169), 68% in South
Africa reported they would if it were more easily available
and 54% in Zimbabwe. More providers in South Africa
(28%) than Zimbabwe (14%) reported that they would
like training on FCs (p≤0.001).
Seventy-one per cent reported routinely counselling
(usually or always) women on FCs; more providers
reported FC counselling for HIV-positive (82%) and
unmarried women (74%), and fewer reported counsel-
ling for married women (66%), women using hormonal
contraception (65%), and female adolescents (55%).
Most of these differences in counselling by patient type
were owing to large variations in Zimbabwe where coun-
selling for HIV-positive women was 93%, but for adoles-
cents was 50% (table 2). In South Africa, there was a
lower level of routine counselling in general (62%), with
little difference among the patient types, ranging from
67% of HIV-positive women to 62% of adolescents.
However, 90% of providers in South Africa reported
routine male condom counselling with female patients
compared with 80% in Zimbabwe. Similar within-
country counselling patterns held true for male
condoms, with 94% routinely counselling female adoles-
cents in South Africa compared to 56% in Zimbabwe.
Support for the FC as a contraceptive method for
HIV-positive women or women at risk of HIV infection
was high overall; in Zimbabwe there was near universal
support for women at risk of HIV infection (98% vs 84%
in South Africa; p≤0.001) or HIV-positive women (97%
and 87%, respectively; p≤0.001; table 2). The large
majority (89%) reported routinely talking to female
patients about pregnancy and HIV/STI prevention in
the same visit. About two-thirds of providers (68%)
believed there is a very high (9 or 10 on a scale of 1–10)
need for more female barrier methods for HIV/STI
prevention.
In multivariable logistic regression, several provider
characteristics were found to be significantly associated
with routine condom counselling (table 3). Providers in
South Africa were significantly less likely to counsel
female patients on the FC (OR=0.48; p≤0.001), and
more likely to counsel on the male condom (OR=2.4;
p≤0.001). Provider age was positively associated with FC
counselling (OR=1.02; p≤0.001), and nurses were signifi-
cantly more likely than physicians to counsel patients on
both FCs (OR=5.4; p≤0.001) and male condoms
(OR=2.6; p≤0.001). HIV prevention training and family
planning training were not associated with FC counsel-
ling. HIV prevention training was associated with male
condom counselling in bivariate models, but in the mul-
tivariable models including a variable for proportion of
Table 1 Provider and practice characteristics
Zimbabwe
(n=830)
South Africa
(n=614)
Total
(N=1444)
Gender, n (%)
Female 674 (82) 547 (90) 1221 (86)
Male 145 (18) 62 (10) 207 (15)
Provider type, n(%)
Nurse 792 (95) 528 (86) 1320 (91)
Physician 38 (5) 86 (14) 124 (9)
Age, median years (range) 39 (20–74) 43 (23–69) 41 (20–74)
Previous training, n (%)
HIV prevention 629 (77) 510 (84) 1139 (80)
Family planning 503 (61) 399 (66) 902 (63)
Type of facility, n (%)
Hospital 484 (59) 309 (50) 793 (55)
Clinic 342 (41) 305 (50) 647 (45)
Location, n (%)
Urban 375 (45) 315 (51) 690 (48)
Rural 451 (55) 299 (49) 750 (52)
Proportion of patients at risk for HIV, n (%)
None/some 175 (22) 46 (8) 221 (16)
Half 112 (14) 92 (15) 204 (14)
Most/all 524 (65) 470 (77) 994 (70)
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patients at risk of HIV (most/all), HIV training was no
longer significant, although high proportion of patients
at risk of HIV was (OR=1.6; p≤0.001). Condom counsel-
ling did not vary by urban versus rural clinical setting or
in clinics or hospitals.
The in-depth interviews gave some insight into the
reasons that some providers might include the FC in coun-
selling, while others might not, and what they think the
best approach is to encourage use. Many providers men-
tioned logistical factors in the interviews that would restrict
access to the method. Providers noted that FCs are more
expensive than male condoms and are not always supplied
to clinics, especially in South Africa, where availability was
frequently mentioned as a problem. Several considered
physical features as method limitations, including discom-
fort and being highly visible.
Alternatively, many providers noted that some men
who will not use a male condom will agree to an FC,
since the women puts it on. Providers noted that the FC
could help empower women since they could ensure it
was used, although they also mentioned that trust issues
related to marriage and condom use arise with the FC
and male condom. Many providers thought that hus-
bands might be more willing to try FCs if they came with
their wives to the clinic and were shown by the provider
how to use it. As a Zimbabwe physician said: “…the
method is a bit awkward. It’s quite difficult to use, so it
really remains for us to encourage the partner to
Table 2 Condom counselling and provision practices and female condom beliefs
Zimbabwe
(n=830)
South Africa
(n=614)
Total
(N=1444)
Currently offers condoms, n (%)
Female condoms*** 756 (94) 483 (80) 1239 (88)
Male condoms 796 (99) 599 (99) 1395 (99)
Would offer female condoms if more easily available, n (%) 230 (31) 129 (22) 359 (27)
Among providers offering female condoms, counsels routinely with…, n (%) (N=1226)
Women in general*** 602 (80) 329 (69) 931 (76)
Female teenagers*** 377 (50) 328 (69) 705 (58)
HIV-positive women*** 711 (95) 352 (74) 1063 (87)
Married women*** 544 (72) 319 (67) 863 (70)
Unmarried women*** 622 (83) 342 (72) 964 (79)
Women using hormonal contraception 500 (67) 336 (71) 836 (68)
Among all providers, counsels routinely on female condoms with…, n (%)
Women in general*** 635 (78) 370 (62) 1005 (71)
Female teenagers*** 403 (50) 372 (62) 775 (55)
HIV-positive women*** 761 (93) 400 (67) 1161 (82)
Married women*** 573 (70) 358 (60) 931 (66)
Unmarried women*** 658 (81) 385 (64) 1043 (74)
Women using hormonal contraception 529 (65) 380 (64) 909 (65)
Among all providers, counsels routinely on male condoms with…, n (%)
Women in general*** 652 (80) 542 (90) 1194 (84)
Female teenagers*** 448 (56) 565 (94) 1013 (72)
HIV-positive women 786 (97) 578 (96) 1364 (96)
Married women*** 610 (75) 514 (85) 1124 (79)
Unmarried women*** 683 (85) 554 (92) 1237 (88)
Women using hormonal contraception*** 537 (66) 535 (90) 1072 (76)
Believes female condoms appropriate contraception for women at risk
of HIV infection, n (%)***
800 (98) 503 (84) 1303 (92)
Believes female condoms appropriate contraception for HIV-positive
women, n (%)***
794 (97) 519 (87) 1313 (93)
Routinely talks to female patients about pregnancy and HIV/STI
prevention in same visit, n (%)
718 (88) 536 (90) 1254 (89)
Believes there is a need for more female barrier methods for HIV/STI prevention, scale 1–10, n (%)
High (9–10) 537 (67) 412 (70) 949 (68)
Medium–high (7–8) 140 (17) 102 (17) 242 (17)
Medium (5–6) 72 (9) 45 (8) 117 (8)
Medium–low (3–4) 23 (3) 7 (1) 30 (2)
Low (1–2) 35 (4) 23 (4) 58 (4)
Would like training on condoms, n (%)
Female condoms*** 112 (14) 165 (28) 277 (20)
Male condoms*** 56 (7) 109 (18) 165 (12)
*p≤0.05; **p≤0.010; ***p≤0.001.
STI, sexually transmitted infection.
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accompany the lady to the surgery for consultation so
that we can have some kind of counselling between
myself and the couple.” While counselling the couple
was frequently brought up by providers, in one clinic the
provider also mentioned clinic support groups with peer
counselling to help women to initiate condom use. In
the interviews most providers explained that in counsel-
ling adolescents, they discussed abstinence and saying
no to sex before marriage, which may explain the
finding in the survey data or lower counselling of adoles-
cents on condom use in Zimbabwe. Some, however, also
mentioned condoms, after abstinence, and in South
Africa, most providers in the interviews reported they
counselled adolescents on abstinence and condoms.
DISCUSSION
The FC was integrated into provider practices in
Southern Africa, but to a lesser extent than the male
condom. Providers in Zimbabwe reported counselling
patients on FCs significantly more than providers in
South Africa, which is likely attributable to the larger
public sector FC programme in Zimbabwe, relative to
population size. Providers across South Africa may have
been less likely to have learnt about the FC owing to the
geographic distance and smaller FC programme per
population. In South Africa, the government has
focused on reaching certain designated clinics with sup-
plies and training so availability is not yet ubiquitous. In
the South African qualitative data, many providers com-
mented that availability in the clinic is still a problem,
although the majority reported in the national survey
that if FCs were more easily available, they would offer
them. As in a previous study from Kenya,14 providers
from both countries noted in interviews that the FC was
not always available in clinics even though it was distribu-
ted in the public sector. FCs, a basic technology, had
counselling patterns that were similar in rural and urban
areas and clinics and hospitals, unlike for more sophisti-
cated technologies which in general are more available
to urban populations or in hospital settings.
Variations in counselling by patient type were wide
in Zimbabwe, with high levels of counselling for
HIV-positive women. In Zimbabwe, providers were much
less likely to report female and male condoms counsel-
ling with adolescents than with women in general, sug-
gesting the need for provider training emphasising the
importance of education of adolescents on safe sex,
perhaps even prior to sexual initiation; less than half of
Zimbabwe adults in the 2010-2011 Demographic and
Health Surveys (DHS), however, supported condom edu-
cation for 12-year-olds to 14-year-olds.7 Zimbabwe provi-
ders were also less likely to report condom counselling
with women using hormonal contraception, signalling
the need for emphasis on dual protection of STIs and
pregnancy. In both countries, providers were less likely
to counsel married women than unmarried women on
FCs, although it is essential to give all women informa-
tion in these high-prevalence settings as many married
women are at risk of acquiring HIV from their marital
partner. Condom use is less common among married
women, although one study of a condom intervention
(female and male) showed increased use among
HIV-positive married women.21 There were some signs
in the qualitative data that providers thought FCs might
be more acceptable in marriage than male condoms in
some cases where the woman would be willing to make
the effort and ensure their use was consistent. However,
Table 3 Condom counselling of female patients among providers in South Africa and Zimbabwe: ORs from multivariable
logistic regression
Routine condom counselling (usually/always) Female condoms OR (95% CI) Male condoms OR (95% CI)
Country
Zimbabwe (reference) __ __
South Africa 0.48*** (0.35 to 0.68) 2.39*** (1.57 to 3.65)
Age (years) 1.02*** (1.02 to 1.05) 1.01 (1.00 to 1.03)
Provider type
Physician (reference) __ __
Nurse 5.41*** (3.26 to 8.98) 2.60** (1.47 to 4.58)
Trained in HIV prevention 0.90 (0.62 to 1.05) 1.35 (0.87 to 2.08)
Trained in family planning 0.98 (0.71 to 1.35) 1.02 (0.70 to 1.51)
Facility type
Hospital (reference) __ __
Clinic 0.88 (0.61 to 1.25) 1.21 (0.76 to 1.94)
Location
Rural (reference) __ __
Urban 0.85 (0.61 to 1.25) 1.42 (0.93 to 2.14)
Most/all patients at HIV risk 1.21 (0.92 to 1.59) 1.58** (1.12 to 2.22)
χ2 (8 degrees of freedom) 96.08 70.24
N 1324 1328
*p≤0.05; ** p≤0.010; ***p≤0.001.
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providers noted trust issues may also arise with FCs.
Another early study from the US identified similar train-
ing needs among providers who saw FCs as appropriate
for only certain groups of women, such as HIV-positive
women.13
A number of providers reported a desire for more FC
training, signalling the need for continued investment
in programmes and policies to support access to the FC
in both countries. Previous research from South Africa
has demonstrated the positive impact of training on pro-
vider attitudes.13 Our results showed that neither having
previous HIV training nor serving a high proportion of
at-risk patients significantly increased likelihood of pro-
vider counselling on FCs. Efforts should be made to
ensure that HIV and family planning training in both
countries include FCs, given the wider availability of sup-
plies in recent years. The finding that nurses were sig-
nificantly more likely than physicians to report
counselling women on both male condoms and FCs
reflects the prominent role that nurses play in preven-
tion counselling; nurses therefore should be a priority
for training as they deliver much of the primary care.
However, physicians should also be prepared to counsel
women and men about their options for dual protection
against pregnancy and STIs.
Providers reported a strong need for new female-
initiated barrier methods for prevention and, similar to
prior research from the USA and South Africa,13 several
providers demonstrated negative attitudes about the aes-
thetics and use of the FC during qualitative interviews.
This finding suggests that current technologies may not
meet all their patient needs or are not adequately well
known or accessible, though it is important to note that
this research was conducted just before the new FC2 was
approved by the USFDA. The reported desire for train-
ing suggests that even as we work to develop new tech-
nologies, we must also invest in programmes and
policies that ensure the potential for available existing
technologies is achieved.
These findings must be considered in light of study
limitations. We did not ask providers directly about stock-
ing of FCs in their healthcare systems or whether they
had prior training in FC counselling. Consequently,
results do not shed light on how many providers in
stocked clinics are providing patients with FC; rather, we
only know how many providers overall, in both
stocked and unstocked clinics, are offering the method.
Provision in stocked clinics, especially with trained provi-
ders, is likely to be higher. Expense to the health system
and availability at the clinic level (in addition to whether
they have had prior training on FC provision) would
influence their ability to provide them and thus the like-
lihood that they counsel patients. Since providers are
reporting on their counselling practices, it is likely that
social desirability bias influenced responses towards
more comprehensive levels of prevention counselling;
therefore, patients for whom we measured low levels of
counselling are likely to be in even greater need of FC
education. Our study also has important strengths. Our
nationally representative surveys (with relatively high
response rates) allow us to generalise about providers’
counselling and provision practices in these two coun-
tries; this is the first research on FC counselling and pro-
vision in Southern Africa to include representative
national samples of providers. Further, very few data
existed previously on FC counselling and provision in
sub-Saharan Africa overall and our study contributes sig-
nificantly to the literature on this topic by providing
information on current provider practices in two high
HIV-prevalence countries.
As discussed by Mantell et al,22 a number of previous
studies have documented the role of providers as ‘gate-
keepers’ to new products and the influence that pro-
vider acceptance of new prevention methods can have
on their successful introduction and uptake. Thus pro-
vider practices and support are essential to the success-
ful integration of the FC into HIV and family planning
services, and ultimately to ensure women can protect
themselves from both STI infection and unintended
pregnancy. Our findings revealed provider support for
the FC as a dual-protection method, and a significant
need for further work promoting provider counselling
in particular with adolescents, married women and
women using hormonal contraception.
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